The preimplantation genetic testing market is likely to witness steady growth over the course of the forecast period. Preimplantation genetic testing is the procedure of testing embryos to identify genetic diseases or defects before implantation. Along with implantation of healthy embryo which results in the genetically healthy baby, the preimplantation genetic testing is done to eliminate the risk of structural chromosome abnormalities, Mendelian disorders, etc. However, preimplantation genetic testing also carries various risks such as multiple pregnancy, birth defects, ovarian hyperstimulation syndrome. Hence, researchers are focusing on developing new technology and methods that can minimize all the possible risks related with the preimplantation genetic testing.
The preimplantation genetic testing market is likely to be influenced by a combination of macroeconomic and microeconomic factors. Due to the changing lifestyle, increasing number of people are suffering from genetic disorders or diseases. Hence there has been a significant demand growth in preimplantation genetic testing. The preimplantation genetic testing is also gaining traction for diagnosing minor disabilities and other serious diseases such as cancer. Researchers are also focusing on using innovative techniques for eliminating the possibility of embryo destruction while preimplantation genetic testing.
According to the latest report by Fact.MR, the preimplantation genetic testing market is expected to experience strong growth. The preimplantation genetic testing market is estimated to reach US$ 575.0 million revenue by 2022 end. Due to the increasing awareness of preimplantation genetic testing to avoid genetic disorders, the rise in a number of healthcare providers and healthcare institutes providing preimplantation genetic testing are the influencing factors contributing to growth of preimplantation genetic testing market.
(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)
Genetic Screening to Emerge as the Highly Preferred Test Type
Genetic screening is expected to be the highly preferred preimplantation genetic testing as compared to genetic diagnosis. Gaining nearly two-third of the preimplantation genetic testing market share in terms of revenue towards 2017 end, genetic screening is estimated to create more than US$ 100 million incremental opportunity throughout the forecast period.
Specialized Clinics to Account for Maximum Share
Among all other end users of preimplantation genetic testing, specialized clinics are expected to experience strong growth. Specialized clinics are estimated to exceed US$ 200 million revenue towards 2022 end. Meanwhile, hospitals are also expected to witness impressive growth in preimplantation genetic testing market.
Preimplantation Genetic Testing to find Largest Application in Embryo HLA Typing for Stem Cell Therapy
Embryo HLA typing for stem cell therapy is expected to show healthy growth from throughout 2017-2022. Embryo HLA typing for stem cell therapy is estimated to create an incremental opportunity exceeding US$ 70 million during 2017-2022.
NGS Technology to Gain Maximum Traction in the Preimplantation Genetic Testing Market
Compared to the various other technologies, NGS is expected to be the technology gaining highest revenue share in the preimplantation genetic testing market. NGS is estimated to exceed US$ 200 million revenue by 2022 end.
The report also profiles companies operating in the preimplantation genetic testing market, which include Agilent Technologies Inc., Abbott Laboratories, CooperSurgical Inc., Oxford Gene Technology IP, Illumina, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Genea Limited, Natera, Inc., Rubicon Genomics, Inc., and CombiMatrix Corporation.
Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR
Preimplantation genetic testing is done to find out specific genetic diseases within embryos. This testing is gaining lot of traction due to the increased risk of various diseases owing to the changing lifestyle. Various healthcare institutes, healthcare providers, and researchers are continuously researching on the preimplantation genetic testing to find new methods to eliminate various risks involved in preimplantation genetic diagnosis. Meanwhile, new technologies are also being developed to find all the possible genetic diseases and disorders. This Fact.MR report analyzes the expansion of global preimplantation genetic testing market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.
The scope of Fact.MR’s report is to analyze the global preimplantation genetic testing market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global preimplantation genetic testing market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to preimplantation genetic testing.
The report commences with a brief information of the global preimplantation genetic testing market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global preimplantation genetic testing market.
The next section offers an overview of the global preimplantation genetic testing market. This comprises an introduction to the market, along with a standard definition of the product – preimplantation genetic testing. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.
The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.
In order to offer readers with up-to-date information about the latest advancements in the global preimplantation genetic testing market, the report provides updates about market opportunities, which can benefit leading providers of preimplantation genetic testing. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for preimplantation genetic testing providers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.
Considering the wide scope of the global preimplantation genetic testing market, the report offers in-depth and segment-wise analysis and forecast. The global market for preimplantation of genetic testing is segmented into test type, end user, application, technology, and region. This segment-wise analysis also provides detailed country-wise forecast on all the key parameters of the market.
The report’s last section comprises of the global preimplantation genetic testing market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global preimplantation genetic testing market.
Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,
- Primary research
- Secondary research
- Trade research
- Focused interviews
- Social media analysis
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.